1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 15 to 80 Sponsor: NCI Protocol IDs: NCI-88-C-02, NCI-T88-0022N, T88-0022
|
|
2.
|
Phase: Phase II Type: Treatment Status: Closed Age: 70 and under Sponsor: NCI, Pharmaceutical / Industry Protocol IDs: RUSH-AML-9754, ALZA-RUSH-AML-9754, NCI-V98-1445, NCT00003405
|
|
3.
|
Phase: Phase II Type: Treatment Status: Completed Age: 20 and over Sponsor: NCI Protocol IDs: OSU-85HO205, NCI-T85-0190D, T85-0190
|
|
4.
|
Phase: Phase II Type: Treatment Status: Completed Age: 15 to 80 Sponsor: NCI Protocol IDs: NCI-88-C-0003B, NCI-T88-0020N, T88-0020
|
|
5.
|
Phase: Phase II Type: Treatment Status: Completed Age: 16 and over Sponsor: NCI Protocol IDs: CCUM-8802, NCI-T88-0121O, T88-0121
|
|
6.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GUMC-19692, NCI-T92-0070D, T92-0070
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GUMC-19992, NCI-T92-0060D, T92-0060
|
|
8.
|
Phase: Phase I Type: Treatment Status: Closed Age: over 18 Sponsor: Protocol IDs: MSKCC-94014, NCI-V94-0461
|
|
9.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-9392, NCI-T93-0059C, T93-0059
|
|
10.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CHNMC-IRB-94146, NCI-T94-0201D, T94-0201
|
|
11.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MAYO-960104, NCI-T96-0083, T96-0083
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-83-C-135, NCI-ROB-831, NCI-T83-1021W, T83-1021
|
|
13.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-8321, NCI-T84-0191D, T84-0191
|
|
14.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-86-C-87, NCI-T86-0122N, T86-0122
|
|
15.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-86-C-222B, NCI-T87-0020N, T87-0020
|
|
16.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 to 75 Sponsor: NCI Protocol IDs: RTOG-8612, RTOG-86-12
|
|
17.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-5480, NCI-T87-0293O, T87-0293
|
|
18.
|
Phase: Phase I Type: Treatment Status: Closed Age: 16 and over Sponsor: NCI Protocol IDs: NU-85X2, NCI-T85-0189O, T85-0189
|
|
19.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: AUS-T88-0120, NCI-T88-0120A, T88-0120
|
|
20.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 to 70 Sponsor: NCI Protocol IDs: YALE-HIC-5034, NCI-T89-0001D, T89-0001
|
|
21.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: UCCRC-5853, NCI-T90-0023D, T90-0023
|
|
22.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: GUMC-13090, NCI-T90-0113O, T90-0113
|
|
23.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: CHNMC-IRB-90131, NCI-T90-0183D, T90-0183
|
|
24.
|
Phase: Phase I Type: Treatment Status: Closed Age: 18 and over Sponsor: NCI Protocol IDs: WCCC-CO-9096, NCI-T90-0237C, T90-0237
|
|
25.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GUMC-91140, NCI-T91-0014D, T91-0014
|